| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 9648 |
| 1 | RANITIDINE HYDROCHLORIDE | 2998 |
| 2 | OMEPRAZOLE MAGNESIUM | 210 |
| 3 | ESOMEPRAZOLE MAGNESIUM | 209 |
| 4 | METHOTREXATE SODIUM | 173 |
| 5 | METHOTREXATE | 151 |
| 6 | OMEPRAZOLE | 144 |
| 7 | ADALIMUMAB | 136 |
| 8 | PREDNISONE | 131 |
| 9 | PREDNISOLONE | 129 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANITIDINE HYDROCHLORIDE | 2998 | 0.0553 |
| 1 | RANITIDINE | 9648 | 0.0488 |
| 2 | SENNOSIDES A AND B | 27 | 0.0164 |
| 3 | ALLOPURINOL SODIUM | 9 | 0.0160 |
| 4 | GLUCAGON | 35 | 0.0083 |
| 5 | RALTEGRAVIR | 27 | 0.0051 |
| 6 | CABOTEGRAVIR SODIUM | 7 | 0.0044 |
| 7 | EPLERENONE | 39 | 0.0030 |
| 8 | CEFUROXIME | 33 | 0.0029 |
| 9 | CICLESONIDE | 31 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 325 |
| 1 | Proton Pump Inhibitor [EPC] | 258 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 253 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 224 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 153 |
| 5 | Atypical Antipsychotic [EPC] | 135 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 134 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 128 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 115 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 111 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 1 | Antihypoglycemic Agent [EPC] | 35 | 0.0082 |
| 2 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 3 | Provitamin D2 Compound [EPC] | 62 | 0.0021 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 4 | 0.0019 |
| 5 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 6 | Glucosylceramide Synthase Inhibitor [EPC] | 4 | 0.0014 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 7 | 0.0011 |
| 9 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |